Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.78 CAD
Change Today 0.00 / 0.00%
Volume 1.1K
COV On Other Exchanges
Symbol
Exchange
Venture
As of 9:30 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

covalon technologies ltd (COV) Snapshot

Open
C$0.78
Previous Close
C$0.78
Day High
C$0.78
Day Low
C$0.78
52 Week High
09/8/14 - C$1.90
52 Week Low
08/24/15 - C$0.76
Market Cap
7.3M
Average Volume 10 Days
7.9K
EPS TTM
C$-0.12
Shares Outstanding
9.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for COVALON TECHNOLOGIES LTD (COV)

Related News

No related news articles were found.

covalon technologies ltd (COV) Related Businessweek News

No Related Businessweek News Found

covalon technologies ltd (COV) Details

Covalon Technologies Ltd. develops, licenses, and sells medical technologies. It operates in two segments, Advanced Wound Care and Specialized Medical Device Coatings. The company provides advanced wound care products comprising ColActive Plus Ag advanced wound care dressings; ColActive Transfer wound contact layers; CovaStat bio-active absorbable hemostatic sponges; and CovaSorb bio-active absorbent foam replacement dressings. It also offers IV Clear and SurgiClear antimicrobial silicone dressings. In addition, the company provides medical coatings that deliver infection control, therapeutic delivery, and lubricity, as well as CovaCoat medical coatings that offers photochemical process for covalently linking coating molecules to various medical device surfaces; and SilverCoat antimicrobial silicone foley catheters. Further, it offers process and manufacturing equipment validation assistance and on-site training services; and professional services, including feasibility studies, product formulation, prototype testing, validation, and manufacturing. The company sells its technologies and products to medical companies and distributors worldwide. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

covalon technologies ltd (COV) Top Compensated Officers

Chief Executive Officer, President, Interim C...
Total Annual Compensation: C$325.0K
Co-Founder and Chief Science Officer
Total Annual Compensation: C$150.0K
Vice President of Operations
Total Annual Compensation: C$155.0K
Senior Director of Global Marketing
Total Annual Compensation: C$139.0K
Compensation as of Fiscal Year 2014.

covalon technologies ltd (COV) Key Developments

Covalon Technologies Ltd. Reports Revenue Results for the Third Quarter Ended June 30, 2015

Covalon Technologies Ltd. reported revenue results for the third quarter ended June 30, 2015. The company reported its financial results for its third quarter ended June 30, 2015, which includes revenue for three months of $1,974,337 and net loss for the quarter of $129,272.   Revenue from advanced wound care product sales for the three month period ended June 30, 2015 increased 56% to $1,741,133 compared to $1,119,559 for the same period last year.  Revenue from specialized medical device coatings for the three month period ended March 31, 2015 was $164,215 compared to $14,100 for the same period of the prior year.

Covalon Technologies Ltd. Reports Earnings Results for the Second Quarter Ended March 31, 2015

Covalon Technologies Ltd. reported earnings results for the second quarter ended March 31, 2015. For the quarter, the company reported revenue of $2,180,276 and net income of $264,340.

Covalon Technologies Ltd., Annual General Meeting, Jun 11, 2015

Covalon Technologies Ltd., Annual General Meeting, Jun 11, 2015., at 15:30 US Eastern Standard Time. Location: Stikeman Elliott LLP. Agenda: To present the financial statements of the corporation for the year ended September 30, 2014, together with the report of the auditor thereon and the unaudited interim consolidated financial statements for the three months ended December 31, 2014; to elect directors for the ensuing year; to reappoint BDO Dunwoody LLP, Chartered Accountants, as auditor and to authorize the directors to fix the auditor's remuneration; to approve and confirm effective the corporation's 2007 Stock Option Plan; and to transact such other business as may properly come before the Meeting or any reconvened meeting following an adjournment or postponement thereof.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COV:CN C$0.78 CAD 0.00

COV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for COV.
View Industry Companies
 

Industry Analysis

COV

Industry Average

Valuation COV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.2x
Price/Book 1.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COVALON TECHNOLOGIES LTD, please visit www.covalon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.